RSS feed source: National Science Foundation

ENG

Division of Chemical, Bioengineering, Environmental, and Transport Systems

  September 01, 2024 – September 16, 2024

  September 01- September 15, Annually Thereafter

ENG

Division of Civil, Mechanical and Manufacturing Innovation

  September 01, 2024 – September 16, 2024

  September 01- September 15, Annually Thereafter

MPS

Division of Chemistry – Chemical Catalysis (CAT), Chemical Mechanism, Function, and Properties (CMFP), Chemical Synthesis (SYN)

  September 01, 2024 – September 30, 2024

  September 01 – September 30, Annually Thereafter

MPS

Division of Materials Research

  October 15, 2024

  October 15, Annually Thereafter

MPS

Division of Astronomical Sciences – Advanced Technologies and Instrumentation

  October 01, 2024

Click this link to continue reading the article on the source website.

RSS feed source: National Science Foundation

Synopsis

NSF-supported science and engineering research increasingly relies on cutting-edge infrastructure. With its Major Research Instrumentation (MRI) program and Major Multi-user Facilities (“Major Facilities”) projects, NSF supports infrastructure projects at the lower and higher range of infrastructure project costs, Foundation-wide, across science and engineering research disciplines. The Foundation-wide Mid-scale Research Infrastructure opportunity is intended to provide NSF with an agile, Foundation-wide process to fund experimental research capabilities in the mid-scale range between MRI and Major Multi-user Facilities.

NSF defines Research Infrastructure (RI) as any combination of facilities, equipment, instrumentation, or computational hardware or software, and the necessary human capital in support of the same. Major facilities and mid-scale projects are subsets of research infrastructure. The NSF Mid-scale Research Infrastructure-1 Program (Mid-scale RI-1) supports either design activities or implementation of unique and compelling RI projects. Mid-scale implementation projects may include any combination of equipment, instrumentation, cyberinfrastructure,

Click this link to continue reading the article on the source website.

RSS feed source: National Science Foundation

Today, CDC Director Mandy Cohen endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation for people 65 years and older and those who are moderately or severely immunocompromised to receive a second dose of 2024-2025 COVID-19 vaccine six months after their first dose.

Click this link to continue reading the article on the source website.